<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS156922</article-id><article-id pub-id-type="doi">10.1101/2022.11.08.515582</article-id><article-id pub-id-type="archive">PPR568818</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Segregation of pathways leading to pexophagy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Barone</surname><given-names>Francesco G.</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Urbé</surname><given-names>Sylvie</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Clague</surname><given-names>Michael J.</given-names></name></contrib><aff id="A1">Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown St., Liverpool, L69 3BX, UK</aff></contrib-group><author-notes><corresp id="CR1"><email>clague@liv.ac.uk</email>, <email>urbe@liv.ac.uk</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>11</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>08</day><month>11</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Peroxisomes are organelles with key roles in metabolism including long-chain fatty acid production. Their metabolic functions overlap and interconnect with mitochondria, with which they share an overlapping but distinct proteome. Both organelles are degraded by selective autophagy processes termed pexophagy and mitophagy. Whilst mitophagy has received intense attention, the pathways linked to pexophagy and associated tools are less well developed. We have identified the neddylation inhibitor, MLN4924, as a potent activator of pexophagy and show that this is mediated by the HIF1α-dependent upregulation of BNIP3L/NIX, a known adaptor for mitophagy. We show that this pathway is distinct from pexophagy induced by the USP30 deubiquitylase inhibitor, CMPD-39, for which we identify the adaptor NBR1 as a central player. Our work suggests a level of complexity to the regulation of peroxisome turnover that includes the capacity to co-ordinate with mitophagy, via NIX, which acts as a rheostat for both processes.</p></abstract><kwd-group><kwd>pexophagy</kwd><kwd>USP30</kwd><kwd>MLN4924</kwd><kwd>ubiquitin</kwd><kwd>peroxisomes</kwd><kwd>NIX</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Selective autophagy requires that an organelle destined for elimination is marked and then linked to the phagophore membrane. This normally occurs via a LC3-interacting region (LIR) that links to lipid modified LC3 (<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref>). In many cases these selective autophagy adaptors are recruited to damaged organelles by binding to ubiquitin, which accumulates on their surface. These include adaptors from the Sequestosome-1-like receptor family that include p62, NBR1, NDP52, TAX1BP1 and OPTN. All of these proteins have both a LIR and a ubiquitin binding domain. Nevertheless, they are differentially associated with various forms of selective autophagy and the underlying reasons are not completely understood (<xref ref-type="bibr" rid="R3">3</xref>). For example, a comparison of these factors in the regulation of ubiquitin-dependent mitophagy suggested that only NDP52 and OPTN play critical roles (<xref ref-type="bibr" rid="R4">4</xref>). In contrast, ubiquitin-dependent pexophagy relies upon NBR1 (<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R6">6</xref>). There is also diversity of mechanism in pathways converging on organelle turnover. For example, mitophagy is induced by mitochondrial depolarisation, activating the PINK1-PRKN pathway which leads to coating the outer mitochondrial surface with ubiquitin and is suppressed by the deubiquitylase (DUB), USP30 (<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R8">8</xref>). However, the vast majority of mitophagy in an organism is PINK1-PRKN independent (<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref>). An alternative ubiquitin-independent pathway exists, that employs trans-membrane domain containing proteins, BNIP3 and BNIP3L/NIX, which insert directly into the polarised mitochondrial membrane and link to the phagophore LC3 by LIR domains (<xref ref-type="bibr" rid="R11">11</xref>). NIX plays a critical role in the removal of mitochondria during reticulocyte development and neuronal differentiation and is up-regulated by hypoxia (<xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R16">16</xref>).</p><p id="P3">Inherited mutations in peroxisomal genes can lead to debilitating peroxisomal disorders. Many of these have been linked to peroxisome biogenesis, but it is now apparent that the other arm of peroxisome homeostasis, namely pexophagy, is also critical (<xref ref-type="bibr" rid="R17">17</xref>,<xref ref-type="bibr" rid="R18">18</xref>). For example, the AAA-ATPase comprised of PEX1, PEX6 and PEX26 is a pexophagy suppressor by virtue of removing the ubiquitylated peroxisomal matrix protein import receptor, Ub-PEX5 from the peroxisomal membrane (<xref ref-type="bibr" rid="R19">19</xref>). This shift into the spotlight has highlighted an unmet need for tools to manipulate pexophagy in a controlled manner. Here we started out surveying a number of candidate compounds and discovered that the neddylation inhibitor MLN4924 and the USP30 inhibitor, compound 39 (CMPD-39) are both potent inducers of pexophagy (<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref>). In a parallel to mitophagy, we show that the MLN4924 effect reflects activation of HIF1α and up-regulation of NIX. In contrast, CMPD-39 promotes a pexophagy pathway that uses the ubiquitin recognising adaptor NBR1, consistent with the proposed mode of action on a DUB previously linked to pexophagy (<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref>). Our results highlight the increasing awareness of the complexity of pexophagy pathways akin to mitophagy and suggest that, in the case of hypoxia/MLN4924 treatment, both organelles can be turned over in a co-ordinated manner.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Survey of pexophagy inducing agents</title><p id="P4">We generated a retinal pigment epithelial (hTERT-RPE1) cell line, expressing a peroxisomal matrix targeting signal joined with a mKeima fluorophore (Keima-SKL). This fluorophore reports on lysosomal delivery of peroxisomes. The lower pH of the lysosome leads to a change in the excitation spectrum properties of the reporter and the resultant pexolysosomes are represented in red pseudocolour (<xref ref-type="fig" rid="F1">Figure 1A</xref>) (<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R24">24</xref>). We conducted a survey of various chemicals, drawn from the literature, for their influence on pexophagy. These included agents linked to peroxisome turnover (4-phenylbutyric acid - 4-PBA, Clofibrate), others previously linked to mitophagy (Deferiprone - DFP, MLN4924) and the USP30 inhibitor CMPD-39, which we have previously shown to promote both pathways as well as a general oxidative stress (<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R25">25</xref>–<xref ref-type="bibr" rid="R27">27</xref>).</p><p id="P5">All agents led to increases in pexophagy indices of similar magnitudes (<xref ref-type="fig" rid="F1">Figure 1B-D</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1A-C</xref>). Both DFP and MLN4924 generate an increase in HIF1α, which in turn drives expression of the mitophagy adaptors, BNIP3 and NIX (<xref ref-type="fig" rid="F1">Figure 1E-H</xref>). DFP inhibits the prolyl hydroxylase enzyme that renders HIF1α a substrate for the Cullin RING ligase VHL, whilst MLN4924 inhibits the neddylation-dependent activation of all Cullins (<xref ref-type="fig" rid="F1">Figure 1E</xref>). We have subsequently focused our efforts on characterising CMPD-39 and MLN4924 because of their high selectivity for their protein targets.</p></sec><sec id="S4"><title>Elevated NIX levels promote pexophagy</title><p id="P6">We next showed that MLN4924-induced pexophagy requires the canonical autophagy machinery as the number of pexolysosomes is sensitive to depletion of the key autophagy orchestrator ATG7 (<xref ref-type="fig" rid="F2">Figure 2A-D</xref>). It is insensitive to depletion of the peroxisomal membrane protein ACBD5, whose yeast counterpart, Atg37, has been strongly linked to pexophagy (<xref ref-type="bibr" rid="R28">28</xref>). However, the combined depletion of BNIP3 and NIX restores pexophagy to baseline levels suggesting that these proteins fully account for the observed effect of MLN4924 (<xref ref-type="fig" rid="F2">Figure 2A-D</xref>). Individual depletions of BNIP3 and NIX indicates that NIX is the principal inducer of pexophagy (<xref ref-type="fig" rid="F2">Figure 2E-H</xref>).</p></sec><sec id="S5"><title>Direct association of NIX with peroxisomes</title><p id="P7">Whilst NIX is known to directly insert into the mitochondrial membrane, its association with peroxisomes has not been previously established. We wished to check if we could observe NIX on peroxisomes and secondly whether this reflects a direct association or transfer from mitochondria. We employed a strategy we have previously used to demonstrate insertion of USP30 directly into the peroxisomal membrane (<xref ref-type="bibr" rid="R22">22</xref>). We elected to effectively remove mitochondria from hTERT-RPE1 cells, stably expressing high levels of YFP-Parkin, by eliciting mitophagy following mitochondrial depolarisation with antimycin and oligomycin (A/O, <xref ref-type="fig" rid="F3">Figure 3A</xref>). Subsequently, cells were transfected with DsRed-NIX and examined by fluorescence microscopy for colocalisation with the peroxisomal marker PMP70 (<xref ref-type="fig" rid="F3">Figure 3B,C</xref>) or harvested for subcellular fractionation (<xref ref-type="fig" rid="F3">Figure 3D</xref>). We find clear evidence for direct association of NIX with peroxisomal membranes under these conditions, suggesting that the effect of NIX on pexophagy reflects this association rather than some indirect consequence of mitophagy.</p></sec><sec id="S6"><title>CMPD-39 induced pexophagy requires NBR1</title><p id="P8">Whilst NIX expression is under the control of ubiquitin E3-ligase activity, the actual pexophagy event does not require organelle coating with ubiquitin, owing to its direct insertion into membranes. Moreover, CMPD-39 does not increase NIX levels (<xref ref-type="fig" rid="F1">Figure 1E,G</xref>). We presumed that USP30 inhibition by CMPD-39 must be promoting autophagy via an alternative ubiquitin-dependent pathway. We thus chose to test a role for the established pexophagy adaptor NBR1 in this system, which acts as a bridge between ubiquitin and LC3. The increased pexophagy following CMPD-39 is insensitive to BNIP3/NIX or ACBD5 depletion but returns to baseline on depletion of ATG7 or NBR1 (<xref ref-type="fig" rid="F4">Figure 4A-D</xref>).</p></sec></sec><sec id="S7" sec-type="discussion"><title>Discussion</title><p id="P9">Here we have used MLN4924 to induce NIX via the HIF1α pathway (<xref ref-type="fig" rid="F4">Figure 4E</xref>). We show that NIX is targeted to peroxisomes and promotes pexophagy. This provides an additional function for NIX beyond its established role in governing mitophagy in various contexts (<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R30">30</xref>). Whilst this manuscript was in preparation, Ganley and colleagues reported similar findings, using the iron chelating drug DFP, to induce HIF1α and hence NIX (<xref ref-type="bibr" rid="R31">31</xref>). In our hands DFP has a stronger pexophagy-promoting effect than MLN4924 despite the latter’s complete inhibition of neddylation. As the CRL2<sup>VHL</sup> complex is the principal regulator of HIF1α stability and requires neddylation for activity, we suggest that there may be additional ill-defined pathways induced by DFP (<xref ref-type="bibr" rid="R32">32</xref>). Both drugs provide a complementary approach to inducing pexophagy and can be usefully cross-referenced with each other in future studies. MLN4924 (otherwise known as Pevonedistat) is well tolerated and has featured in more than thirty oncology related clinical trials (<xref ref-type="bibr" rid="R33">33</xref>). In this disease context, up-regulation of the HIF1α pathway is not desirable and our work highlights that consideration should be given to combination therapy together with HIF pathway inhibitors.</p><p id="P10">It has been estimated that 2/3 of the respective proteomes of mitochondria and peroxisomes overlap (<xref ref-type="bibr" rid="R34">34</xref>). There are close contacts between the two organelles and some mitochondrial material can be delivered to peroxisomes via vesicular transport (<xref ref-type="bibr" rid="R35">35</xref>). We have previously shown that USP30 can be directly targeted to peroxisomes in cells lacking mitochondria (<xref ref-type="bibr" rid="R22">22</xref>). We now show that the same holds true for NIX. Thus the effect of NIX on pexophagy does not require its traversal through mitochondria.</p><p id="P11">We have also previously shown CMPD-39 induces pexophagy (<xref ref-type="bibr" rid="R21">21</xref>). Here, we have been able to compare the magnitude of this effect with other agents. In our survey of pexophagy inducing chemicals, CMPD-39 induced pexophagy to a similar degree as MLN4924. However, CMPD-39 induced pexophagy is entirely dependent on NBR1 and this distinguishes it from the MLN4924-NIX pathway (<xref ref-type="fig" rid="F4">Figure 4E</xref>). The ubiquitin-binding pexophagy adaptor, NBR1, has previously been shown to be necessary and sufficient for basal pexophagy (<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R36">36</xref>). The simplest model predicts that peroxisome localised USP30 suppresses critical ubiquitin signals that otherwise lead to pexophagy (<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref>). This concords with the proposed role of USP30 in mitophagy, although the downstream adaptor may vary (<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R30">30</xref>,<xref ref-type="bibr" rid="R37">37</xref>–<xref ref-type="bibr" rid="R43">43</xref>). Riccio and colleagues have suggested that USP30 suppresses peroxisome ubiquitylation attributed to the peroxisomal E3 ligase PEX2 (<xref ref-type="bibr" rid="R23">23</xref>). More recently Zheng and colleagues have shown that the E3 ligase MARCH5 is shared between mitochondria and peroxisomes and can also promote pexophagy (<xref ref-type="bibr" rid="R44">44</xref>). At mitochondria, MARCH5 and USP30 have been shown to reciprocally regulate the ubiquitin status of the mitochondrial import (TOMM) complex (<xref ref-type="bibr" rid="R41">41</xref>). We have proposed that this sets a trigger threshold for unleashing the PINK1-PRKN cascade (<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R42">42</xref>,<xref ref-type="bibr" rid="R45">45</xref>). We speculate that a MARCH5/USP30 counterpoise system may be preserved at the peroxisome and is disrupted by CMPD-39. Both pexophagy pathways, whose induction we have chemically segregated here, have key factors in common with established mitophagy pathways (<xref ref-type="fig" rid="F4">Figure 4E</xref>). Given the metabolic interplay between these two organelles, one can imagine advantages in regulating their abundance in a co-ordinated manner.</p></sec><sec id="S8" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S9"><title>Cell culture, transfection and RNA interference</title><p id="P12">hTERT-RPE1-Keima-SKL and hTERT-RPE1-YFP-Parkin cells were routinely cultured in Dulbecco’s Modified Eagle’s medium DMEM/F12 (Gibco, 31331028) supplemented with 10% FBS (Gibco, 10270106), 1% non-essential amino acids (Gibco, 111505035) and 1% penicillin/streptomycin at 37°C and 5% CO<sub>2</sub>. Cells were routinely checked for mycoplasma. For RNA interference experiments, cells were treated with 40 nM of non-targeting (NT1) or target specific siRNA oligonucletotides (Dharmacon On-target plus smart pool), using Lipofectamine RNAi-MAX (Invitrogen, 13778030) according to manufacturer’s instructions. For plasmid transfections, Lipofectamine 3000 (Invitrogen, L3000001) was used according to the manufacturers instructions.</p></sec><sec id="S10"><title>Generation of the pexophagy reporter hTERT-RPE1-Keima-SKL cell line</title><p id="P13">hTERT-RPE1-Cas9i-PuroS cells (<xref ref-type="bibr" rid="R46">46</xref>), were transfected with pCDNA3.1-mKeima-SKL-BlastR (derived from pCDNA3.1-mKeima-SKL-Neo (<xref ref-type="bibr" rid="R22">22</xref>)), using Lipofectamine 2000 (Invitrogen, 11668019). Transfected cells were selected with 10 μg/ml Blasticidin S HCl for 7 days and mKeima positive cells were isolated by FACS. A clonally isolated cell line expressing suitable levels of the mKeima-SKL reporter was selected and is referred to as hTERT-RPE1-Keima-SKL for all experiments in this paper.</p></sec><sec id="S11"><title>siRNA and plasmids</title><p id="P14">The following ON-Target Plus Smart Pool siRNAs were obtained from Dharmacon: BNIP3 (5’ -UCGCAGACACCACAAGAUA-3’, 5’ -GAACUGCACUUCAGCAAUA-3’, 5’ -GGAAAGAAGUUGAAAGCAU-3’, 5’-ACACGAGCGUCAUGAAGAA-3’), BNIP3L/NIX (5’-GACCAUAGCUCUCAGUCAG-3’, 5’-CAACAACAACUGCGAGGAA-3’, 5’-GAAGGAAGUCGAGGCUUUG-3’, 5’-GAGAAUUGUUUCAGAGUUA-3’), ATG7 (5’-CCAACACACUCGAGUCUUU-3’, 5’-GAUCUAAAUCUCAAACUGA-3’, 5’-GCCCACAGAUGGAGUAGCA-3’, 5’-GCCAGAGGAUUCAACAUGA-3’. ACBD5 (5’-CUAAAGGGAUCUACUACUA-3’, 5’-CCAAAACCGUUAAUGGUAA-3’, 5’-CAGCAUUUGACAAGCGAUU-3’, 5’-GGAUGCAACACUUGAGCGA-3’. NBR1 (5’-GAGAACAAGUGGUUAACGA-3’, 5’-CCACAUGACAGUCCUUUAA-3’, 5’-GAACGUAUACUUCCCAUUG-3’, 5’-AGAAGCCACUUGCACAUUA-3’. DsRed-BNIP3L/NIX plasmid was obtained from Addgene (100763). DsRed-N1 plasmid was a gift from Francis Barr (University of Oxford).</p></sec><sec id="S12"><title>Antibodies and reagents</title><p id="P15">Antibodies and other reagents used were as follows: anti-BNIP3L (Cell Signalling, #12396, 1:1000 WB), anti-BNIP3 (Abcam, ab109362, 1:1000 WB), anti-TOM20 (ProteinTech, 11802-1-AP, 1:1000 WB), anti-TOM20 (Sigma, HPA011562, 1:500 IF), anti-PMP70 (Sigma, SAB4200181, 1:1000 WB, 1:250 IF), mouse anti-actin (ProteinTech, 66009-1-Ig, 1:10,000), anti-Cullin2 (Bethyl, A302-476A, 1:2000 WB), anti-HIF1α (NB100-134, 1:1000, Novus Bio techne), anti-ATG7 (Cell Signalling, 2631, 1:1000 WB), anti-NBR1 (Cell Signalling, 9891S, 1:1000 WB), MLN4924 (Chemgood, C-1231), Deferiprone (Sigma, 379409), 4-PBA (Sigma, 21005), Clofibrate (Sigma, C6643), Hydrogen peroxide (Sigma, H1009), oligomycin A (Sigma, 75351), antimycin A (Sigma, A8674).</p></sec><sec id="S13"><title>Preparation of cell lysates and Western blot analysis</title><p id="P16">Cultured cells were lysed with RIPA (150 mM Sodium chloride (Fisher Scientific, S316060), 1% Sodium deoxycholate, 0.1% SDS, 1% Triton X-100) lysis buffer and routinely supplemented with mammalian protease inhibitor cocktail (Sigma, P8340) and Phostop (Roche, 04906837001). Proteins were resolved using SDS–PAGE (Invitrogen NuPage gel 4–12%, NP0321/NP0335), transferred to nitrocellulose membrane (Amersham, 10600002), blocked in 5% milk (Marvel) or 5% BSA (First Link, 41-10-410) in TBS (20mM Tris-Cl pH 7.6, 150mM NaCl) supplemented with Tween-20 (Fisher Scientific, 10485733), and probed with primary antibodies overnight. Visualisation and quantification of Western blots were performed using IRdye 800CW and 680LT coupled secondary antibodies and an Odyssey infrared scanner (LI-COR Biosciences, Lincoln, NE).</p></sec><sec id="S14"><title>Mitochondria depletion assay</title><p id="P17">As previously described (<xref ref-type="bibr" rid="R22">22</xref>), hTERT-RPE1 cells stably overexpressing YFP-Parkin (hTERT-RPE1-YFP-Parkin) were treated for 24 h with Antimycin A (1 <italic>μ</italic>M) and Oligomycin A (1 <italic>μ</italic>M), washed with PBS and cultured in normal media prior to transfection with a plasmid expressing DsRED alone or DsRed-BNIP3L/NIX (<xref ref-type="bibr" rid="R22">22</xref>). After 16 hours, cells were fixed for immunofluorescence microscopy or harvested for subcellular fractionation.</p></sec><sec id="S15"><title>Subcellular fractionation</title><p id="P18">hTERT-RPE1-YFP-Parkin cells were washed twice with ice-cold PBS, followed by centrifugation at 1000g for 2 min at 4°C. Cell pellets were resuspended in HIM buffer (200 mM Mannitol, 70 mM Sucrose, 1mM EGTA and 10 mM Hepes-NaOH, pH 7.4) and centrifuged again at 1000g for 5 min at 4°C. The cell pellet was resuspended in HIM buffer, supplemented with 50 mM 2-Chloroacetamide, mammalian protease inhibitor cocktail (Sigma, P8340) and Phostop (Roche, 04906837001), before cells were mechanically disrupted by shearing with a 23 gauge needle. The cell homogenate was then centrifuged at 600 g for 10 min to obtain the post-nuclear supernatant (PNS). Heavy membranes enriched in mitochondria were removed by centrifugation at 7000 g for 15 min and the supernatant was centrifuged at 100,000 g for 30 min to generate the light membrane pellet fraction (LM). Equal amount of protein from both PNS and LM (10 μg/lane) was resolved by SDS-PAGE (Invitrogen NuPage gel 4–12%).</p></sec><sec id="S16"><title>Immunofluorescence and colocalization analysis</title><p id="P19">hTERT-RPE1-YFP-Parkin cells were fixed using 4% paraformaldehyde in PBS, permeabilised with 0.2% Triton X-100 in PBS, stained with AlexaFluor-405 or -594 coupled secondary antibodies and imaged using a Zeiss LSM900 with Airyscan (63× NA 1.4 oil, acquisition software Zen Blue). The images were processed using Adobe Photoshop 2022 and Fiji v2.9.0 software. For colocalisation analysis, single confocal z-planes were analysed with the JaCoP plugin in Fiji v2.9.0 to derive the Manders overlap coefficient (MOC) M1. Quantification of colocalisation was performed from three independent experiments analysing &gt;25 cells per experiment.</p></sec><sec id="S17"><title>Live cell imaging of pexophagy</title><p id="P20">For live cell imaging, hTERT-RPE1-Keima-SKL cells were seeded onto an IBIDI μ-Dish (2x10<sup>5</sup>) (IBIDI, 81156) two days before image acquisition using a 3i Marianas spinning disk confocal microscope (63x oil objective, NA 1.4, Photometrics Evolve EMCCD camera, Slide Book 3i v3.0). Live cells were imaged sequentially (Ex445/Em600 then Ex561/Em600). Images were processed using Adobe Photoshop 2022 and Fiji v2.9.0 softwares. Analysis of pexophagy levels in hTERT-RPE1-Keima-SKL was performed using the semi-automated ‘mito-QC Counter’ plugin implemented in Fiji v2.9.0 software as previously described (<xref ref-type="bibr" rid="R47">47</xref>). The analysis of pexophagy was performed for three independent experiments analysing &gt;40 cells per condition in each experiment.</p></sec><sec id="S18"><title>Statistical analysis</title><p id="P21">P-values are indicated as *P&lt;0.05, **P&lt;0.01, ***P&lt;0.001, ****P&lt;0.0001 and derived by one-way ANOVA and Bonferroni’s multiple comparisons post hoc test. All statistical analysis was conducted using GraphPad Prism 9.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Figure 1</label><media xlink:href="EMS156922-supplement-Supplementary_Figure_1.pdf" mimetype="application" mime-subtype="pdf" id="d14aAdEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S19"><title>Acknowledgements</title><p>hTERT-RPE1-YFP-Parkin cells were a kind gift of Jon Lane (University of Bristol). FGB was funded by a Wellcome Trust PhD studentship, 102172/B/13/Z. MJC is a Royal Society Industry Fellow, INF\R2\212031. Additional support was provided by Bristol-Myers Squibb.</p></ack><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>T</given-names></name><name><surname>Lamark</surname><given-names>T</given-names></name></person-group><article-title>Selective Autophagy: ATG8 Family Proteins, LIR Motifs and Cargo Receptors</article-title><source>J Mol Biol</source><year>2020</year><volume>432</volume><fpage>80</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">31310766</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamark</surname><given-names>T</given-names></name><name><surname>Johansen</surname><given-names>T</given-names></name></person-group><article-title>Mechanisms of Selective Autophagy</article-title><source>Annu Rev Cell Dev Biol</source><year>2021</year><volume>37</volume><fpage>143</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">34152791</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gubas</surname><given-names>A</given-names></name><name><surname>Dikic</surname><given-names>I</given-names></name></person-group><article-title>A guide to the regulation of selective autophagy receptors</article-title><source>FEBS J</source><year>2022</year><volume>289</volume><fpage>75</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">33730405</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarou</surname><given-names>M</given-names></name><name><surname>Sliter</surname><given-names>DA</given-names></name><name><surname>Kane</surname><given-names>LA</given-names></name><name><surname>Sarraf</surname><given-names>SA</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Burman</surname><given-names>JL</given-names></name><name><surname>Sideris</surname><given-names>DP</given-names></name><name><surname>Fogel</surname><given-names>AI</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy</article-title><source>Nature</source><year>2015</year><volume>524</volume><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="pmcid">PMC5018156</pub-id><pub-id pub-id-type="pmid">26266977</pub-id><pub-id pub-id-type="doi">10.1038/nature14893</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deosaran</surname><given-names>E</given-names></name><name><surname>Larsen</surname><given-names>KB</given-names></name><name><surname>Hua</surname><given-names>R</given-names></name><name><surname>Sargent</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lamark</surname><given-names>T</given-names></name><name><surname>Jauregui</surname><given-names>M</given-names></name><name><surname>Law</surname><given-names>K</given-names></name><name><surname>Lippincott-Schwartz</surname><given-names>J</given-names></name><name><surname>Brech</surname><given-names>A</given-names></name><etal/></person-group><article-title>NBR1 acts as an autophagy receptor for peroxisomes</article-title><source>J Cell Sci</source><year>2013</year><volume>126</volume><fpage>939</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">23239026</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>NL</given-names></name><name><surname>Kournoutis</surname><given-names>A</given-names></name><name><surname>Lamark</surname><given-names>T</given-names></name><name><surname>Johansen</surname><given-names>T</given-names></name></person-group><article-title>NBR1: The archetypal selective autophagy receptor</article-title><source>J Cell Biol</source><year>2022</year><volume>221</volume><pub-id pub-id-type="pmcid">PMC9582228</pub-id><pub-id pub-id-type="pmid">36255390</pub-id><pub-id pub-id-type="doi">10.1083/jcb.202208092</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bingol</surname><given-names>B</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><article-title>Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond</article-title><source>Free Radic Biol Med</source><year>2016</year><volume>100</volume><fpage>210</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">27094585</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickles</surname><given-names>S</given-names></name><name><surname>Vigie</surname><given-names>P</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance</article-title><source>Curr Biol</source><year>2018</year><volume>28</volume><fpage>R170</fpage><lpage>R185</lpage><pub-id pub-id-type="pmcid">PMC7255410</pub-id><pub-id pub-id-type="pmid">29462587</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2018.01.004</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Sanchez-Martinez</surname><given-names>A</given-names></name><name><surname>Zarate</surname><given-names>AM</given-names></name><name><surname>Beninca</surname><given-names>C</given-names></name><name><surname>Mayor</surname><given-names>U</given-names></name><name><surname>Clague</surname><given-names>MJ</given-names></name><name><surname>Whitworth</surname><given-names>AJ</given-names></name></person-group><article-title>Basal mitophagy is widespread in Drosophila but minimally affected by loss of Pink1 or parkin</article-title><source>J Cell Biol</source><year>2018</year><volume>217</volume><fpage>1613</fpage><lpage>1622</lpage><pub-id pub-id-type="pmcid">PMC5940313</pub-id><pub-id pub-id-type="pmid">29500189</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201801044</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McWilliams</surname><given-names>TG</given-names></name><name><surname>Prescott</surname><given-names>AR</given-names></name><name><surname>Montava-Garriga</surname><given-names>L</given-names></name><name><surname>Ball</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>F</given-names></name><name><surname>Barini</surname><given-names>E</given-names></name><name><surname>Muqit</surname><given-names>MMK</given-names></name><name><surname>Brooks</surname><given-names>SP</given-names></name><name><surname>Ganley</surname><given-names>IG</given-names></name></person-group><article-title>Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand</article-title><source>Cell Metab</source><year>2018</year><volume>27</volume><fpage>439</fpage><lpage>449</lpage><elocation-id>e435</elocation-id><pub-id pub-id-type="pmcid">PMC5807059</pub-id><pub-id pub-id-type="pmid">29337137</pub-id><pub-id pub-id-type="doi">10.1016/j.cmet.2017.12.008</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ney</surname><given-names>PA</given-names></name></person-group><article-title>Mitochondrial autophagy: Origins, significance, and role of BNIP3 and NIX</article-title><source>Biochim Biophys Acta</source><year>2015</year><volume>1853</volume><fpage>2775</fpage><lpage>2783</lpage><pub-id pub-id-type="pmid">25753537</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweers</surname><given-names>RL</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Randall</surname><given-names>MS</given-names></name><name><surname>Loyd</surname><given-names>MR</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Dorsey</surname><given-names>FC</given-names></name><name><surname>Kundu</surname><given-names>M</given-names></name><name><surname>Opferman</surname><given-names>JT</given-names></name><name><surname>Cleveland</surname><given-names>JL</given-names></name><name><surname>Miller</surname><given-names>JL</given-names></name><name><surname>Ney</surname><given-names>PA</given-names></name></person-group><article-title>NIX is required for programmed mitochondrial clearance during reticulocyte maturation</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>19500</fpage><lpage>19505</lpage><pub-id pub-id-type="pmcid">PMC2148318</pub-id><pub-id pub-id-type="pmid">18048346</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0708818104</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazure</surname><given-names>NM</given-names></name><name><surname>Pouyssegur</surname><given-names>J</given-names></name></person-group><article-title>Hypoxia-induced autophagy: cell death or cell survival?</article-title><source>Curr Opin Cell Biol</source><year>2010</year><volume>22</volume><fpage>177</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">20022734</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Ney</surname><given-names>PA</given-names></name></person-group><article-title>Reticulocyte mitophagy: monitoring mitochondrial clearance in a mammalian model</article-title><source>Autophagy</source><year>2010</year><volume>6</volume><fpage>405</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">20200480</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteban-Martinez</surname><given-names>L</given-names></name><name><surname>Sierra-Filardi</surname><given-names>E</given-names></name><name><surname>McGreal</surname><given-names>RS</given-names></name><name><surname>Salazar-Roa</surname><given-names>M</given-names></name><name><surname>Marino</surname><given-names>G</given-names></name><name><surname>Seco</surname><given-names>E</given-names></name><name><surname>Durand</surname><given-names>S</given-names></name><name><surname>Enot</surname><given-names>D</given-names></name><name><surname>Grana</surname><given-names>O</given-names></name><name><surname>Malumbres</surname><given-names>M</given-names></name><name><surname>Cvekl</surname><given-names>A</given-names></name><etal/></person-group><article-title>Programmed mitophagy is essential for the glycolytic switch during cell differentiation</article-title><source>EMBO J</source><year>2017</year><volume>36</volume><fpage>1688</fpage><lpage>1706</lpage><pub-id pub-id-type="pmcid">PMC5470043</pub-id><pub-id pub-id-type="pmid">28465321</pub-id><pub-id pub-id-type="doi">10.15252/embj.201695916</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordureau</surname><given-names>A</given-names></name><name><surname>Kraus</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>An</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Ahfeldt</surname><given-names>T</given-names></name><name><surname>Paulo</surname><given-names>JA</given-names></name><name><surname>Harper</surname><given-names>JW</given-names></name></person-group><article-title>Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagy</article-title><source>Mol Cell</source><year>2021</year><volume>81</volume><fpage>5082</fpage><lpage>5098</lpage><elocation-id>e5011</elocation-id><pub-id pub-id-type="pmcid">PMC8688335</pub-id><pub-id pub-id-type="pmid">34699746</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2021.10.001</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipolla</surname><given-names>CM</given-names></name><name><surname>Lodhi</surname><given-names>IJ</given-names></name></person-group><article-title>Peroxisomal Dysfunction in Age-Related Diseases</article-title><source>Trends Endocrinol Metab</source><year>2017</year><volume>28</volume><fpage>297</fpage><lpage>308</lpage><pub-id pub-id-type="pmcid">PMC5366081</pub-id><pub-id pub-id-type="pmid">28063767</pub-id><pub-id pub-id-type="doi">10.1016/j.tem.2016.12.003</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>DH</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Jo</surname><given-names>DS</given-names></name><name><surname>Choe</surname><given-names>SK</given-names></name><name><surname>Jo</surname><given-names>EK</given-names></name></person-group><article-title>Pexophagy: Molecular Mechanisms and Implications for Health and Diseases</article-title><source>Mol Cells</source><year>2018</year><volume>41</volume><fpage>55</fpage><lpage>64</lpage><pub-id pub-id-type="pmcid">PMC5792714</pub-id><pub-id pub-id-type="pmid">29370694</pub-id><pub-id pub-id-type="doi">10.14348/molcells.2018.2245</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>KB</given-names></name><name><surname>Bronte-Tinkew</surname><given-names>D</given-names></name><name><surname>Di Pietro</surname><given-names>E</given-names></name><name><surname>Snowden</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>RO</given-names></name><name><surname>Moser</surname><given-names>A</given-names></name><name><surname>Brumell</surname><given-names>JH</given-names></name><name><surname>Braverman</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>PK</given-names></name></person-group><article-title>The peroxisomal AAA ATPase complex prevents pexophagy and development of peroxisome biogenesis disorders</article-title><source>Autophagy</source><year>2017</year><volume>13</volume><fpage>868</fpage><lpage>884</lpage><pub-id pub-id-type="pmcid">PMC5446072</pub-id><pub-id pub-id-type="pmid">28521612</pub-id><pub-id pub-id-type="doi">10.1080/15548627.2017.1291470</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soucy</surname><given-names>TA</given-names></name><name><surname>Smith</surname><given-names>PG</given-names></name><name><surname>Milhollen</surname><given-names>MA</given-names></name><name><surname>Berger</surname><given-names>AJ</given-names></name><name><surname>Gavin</surname><given-names>JM</given-names></name><name><surname>Adhikari</surname><given-names>S</given-names></name><name><surname>Brownell</surname><given-names>JE</given-names></name><name><surname>Burke</surname><given-names>KE</given-names></name><name><surname>Cardin</surname><given-names>DP</given-names></name><name><surname>Critchley</surname><given-names>S</given-names></name><name><surname>Cullis</surname><given-names>CA</given-names></name><etal/></person-group><article-title>An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>732</fpage><lpage>736</lpage><pub-id pub-id-type="pmid">19360080</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusilowicz-Jones</surname><given-names>EV</given-names></name><name><surname>Barone</surname><given-names>FG</given-names></name><name><surname>Lopes</surname><given-names>FM</given-names></name><name><surname>Stephen</surname><given-names>E</given-names></name><name><surname>Mortiboys</surname><given-names>H</given-names></name><name><surname>Urbe</surname><given-names>S</given-names></name><name><surname>Clague</surname><given-names>MJ</given-names></name></person-group><article-title>Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy</article-title><source>Life Sci Alliance</source><year>2022</year><volume>5</volume><pub-id pub-id-type="pmcid">PMC8645336</pub-id><pub-id pub-id-type="pmid">34844982</pub-id><pub-id pub-id-type="doi">10.26508/lsa.202101287</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcassa</surname><given-names>E</given-names></name><name><surname>Kallinos</surname><given-names>A</given-names></name><name><surname>Jardine</surname><given-names>J</given-names></name><name><surname>Rusilowicz-Jones</surname><given-names>EV</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name><name><surname>Kuehl</surname><given-names>S</given-names></name><name><surname>Islinger</surname><given-names>M</given-names></name><name><surname>Clague</surname><given-names>MJ</given-names></name><name><surname>Urbe</surname><given-names>S</given-names></name></person-group><article-title>Dual role of USP30 in controlling basal pexophagy and mitophagy</article-title><source>EMBO Rep</source><year>2018</year><volume>19</volume><elocation-id>e45595</elocation-id><pub-id pub-id-type="pmcid">PMC6030704</pub-id><pub-id pub-id-type="pmid">29895712</pub-id><pub-id pub-id-type="doi">10.15252/embr.201745595</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riccio</surname><given-names>V</given-names></name><name><surname>Demers</surname><given-names>N</given-names></name><name><surname>Hua</surname><given-names>R</given-names></name><name><surname>Vissa</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>DT</given-names></name><name><surname>Strilchuk</surname><given-names>AW</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>McQuibban</surname><given-names>GA</given-names></name><name><surname>Kim</surname><given-names>PK</given-names></name></person-group><article-title>Deubiquitinating enzyme USP30 maintains basal peroxisome abundance by regulating pexophagy</article-title><source>J Cell Biol</source><year>2019</year><volume>218</volume><fpage>798</fpage><lpage>807</lpage><pub-id pub-id-type="pmcid">PMC6400567</pub-id><pub-id pub-id-type="pmid">30700497</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201804172</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>H</given-names></name><name><surname>Kogure</surname><given-names>T</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Yoshimori</surname><given-names>T</given-names></name><name><surname>Miyawaki</surname><given-names>A</given-names></name></person-group><article-title>A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery</article-title><source>Chem Biol</source><year>2011</year><volume>18</volume><fpage>1042</fpage><lpage>1052</lpage><pub-id pub-id-type="pmid">21867919</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>GF</given-names></name><name><surname>Toth</surname><given-names>R</given-names></name><name><surname>James</surname><given-names>J</given-names></name><name><surname>Ganley</surname><given-names>IG</given-names></name></person-group><article-title>Loss of iron triggers PINK1/ Parkin-independent mitophagy</article-title><source>EMBO Rep</source><year>2013</year><volume>14</volume><fpage>1127</fpage><lpage>1135</lpage><pub-id pub-id-type="pmcid">PMC3981094</pub-id><pub-id pub-id-type="pmid">24176932</pub-id><pub-id pub-id-type="doi">10.1038/embor.2013.168</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>KM</given-names></name><name><surname>Schonenberger</surname><given-names>MJ</given-names></name><name><surname>Trotzmuller</surname><given-names>M</given-names></name><name><surname>Horn</surname><given-names>M</given-names></name><name><surname>Elsasser</surname><given-names>HP</given-names></name><name><surname>Moser</surname><given-names>AB</given-names></name><name><surname>Lucas</surname><given-names>MS</given-names></name><name><surname>Schwarz</surname><given-names>T</given-names></name><name><surname>Gerber</surname><given-names>PA</given-names></name><name><surname>Faust</surname><given-names>PL</given-names></name><name><surname>Moch</surname><given-names>H</given-names></name><etal/></person-group><article-title>Hif-2alpha promotes degradation of mammalian peroxisomes by selective autophagy</article-title><source>Cell Metab</source><year>2014</year><volume>20</volume><fpage>882</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">25440060</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Tripathi</surname><given-names>DN</given-names></name><name><surname>Jing</surname><given-names>J</given-names></name><name><surname>Alexander</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Powell</surname><given-names>RT</given-names></name><name><surname>Dere</surname><given-names>R</given-names></name><name><surname>Tait-Mulder</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Paull</surname><given-names>TT</given-names></name><name><surname>Pandita</surname><given-names>RK</given-names></name><etal/></person-group><article-title>ATM functions at the peroxisome to induce pexophagy in response to ROS</article-title><source>Nat Cell Biol</source><year>2015</year><volume>17</volume><fpage>1259</fpage><lpage>1269</lpage><pub-id pub-id-type="pmcid">PMC4589490</pub-id><pub-id pub-id-type="pmid">26344566</pub-id><pub-id pub-id-type="doi">10.1038/ncb3230</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazarko</surname><given-names>TY</given-names></name><name><surname>Ozeki</surname><given-names>K</given-names></name><name><surname>Till</surname><given-names>A</given-names></name><name><surname>Ramakrishnan</surname><given-names>G</given-names></name><name><surname>Lotfi</surname><given-names>P</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Subramani</surname><given-names>S</given-names></name></person-group><article-title>Peroxisomal Atg37 binds Atg30 or palmitoyl-CoA to regulate phagophore formation during pexophagy</article-title><source>J Cell Biol</source><year>2014</year><volume>204</volume><fpage>541</fpage><lpage>557</lpage><pub-id pub-id-type="pmcid">PMC3926955</pub-id><pub-id pub-id-type="pmid">24535825</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201307050</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellot</surname><given-names>G</given-names></name><name><surname>Garcia-Medina</surname><given-names>R</given-names></name><name><surname>Gounon</surname><given-names>P</given-names></name><name><surname>Chiche</surname><given-names>J</given-names></name><name><surname>Roux</surname><given-names>D</given-names></name><name><surname>Pouyssegur</surname><given-names>J</given-names></name><name><surname>Mazure</surname><given-names>NM</given-names></name></person-group><article-title>Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains</article-title><source>Mol Cell Biol</source><year>2009</year><volume>29</volume><fpage>2570</fpage><lpage>2581</lpage><pub-id pub-id-type="pmcid">PMC2682037</pub-id><pub-id pub-id-type="pmid">19273585</pub-id><pub-id pub-id-type="doi">10.1128/MCB.00166-09</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordureau</surname><given-names>A</given-names></name><name><surname>Paulo</surname><given-names>JA</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>An</surname><given-names>H</given-names></name><name><surname>Swatek</surname><given-names>KN</given-names></name><name><surname>Cannon</surname><given-names>JR</given-names></name><name><surname>Wan</surname><given-names>Q</given-names></name><name><surname>Komander</surname><given-names>D</given-names></name><name><surname>Harper</surname><given-names>JW</given-names></name></person-group><article-title>Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling</article-title><source>Mol Cell</source><year>2020</year><volume>77</volume><fpage>1124</fpage><lpage>1142</lpage><elocation-id>e1110</elocation-id><pub-id pub-id-type="pmcid">PMC7098486</pub-id><pub-id pub-id-type="pmid">32142685</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2019.11.013</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>LP</given-names></name><name><surname>Zapata-Munoz</surname><given-names>J</given-names></name><name><surname>Villarejo-Zori</surname><given-names>B</given-names></name><name><surname>Pellegrin</surname><given-names>S</given-names></name><name><surname>Freire</surname><given-names>CM</given-names></name><name><surname>Toye</surname><given-names>AM</given-names></name><name><surname>Boya</surname><given-names>P</given-names></name><name><surname>Ganley</surname><given-names>IG</given-names></name></person-group><article-title>BNIP3L/NIX regulates both mitophagy and pexophagy</article-title><source>EMBO J</source><year>2022</year><elocation-id>e111115</elocation-id><pub-id pub-id-type="pmid">36215693</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stickle</surname><given-names>NH</given-names></name><name><surname>Chung</surname><given-names>J</given-names></name><name><surname>Klco</surname><given-names>JM</given-names></name><name><surname>Hill</surname><given-names>RP</given-names></name><name><surname>Kaelin</surname><given-names>WG</given-names><suffix>Jr</suffix></name><name><surname>Ohh</surname><given-names>M</given-names></name></person-group><article-title>pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>3251</fpage><lpage>3261</lpage><pub-id pub-id-type="pmcid">PMC381603</pub-id><pub-id pub-id-type="pmid">15060148</pub-id><pub-id pub-id-type="doi">10.1128/MCB.24.8.3251-3261.2004</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barghout</surname><given-names>SH</given-names></name><name><surname>Schimmer</surname><given-names>AD</given-names></name></person-group><article-title>E1 Enzymes as Therapeutic Targets in Cancer</article-title><source>Pharmacol Rev</source><year>2021</year><volume>73</volume><fpage>1</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">33177128</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartwig</surname><given-names>S</given-names></name><name><surname>Knebel</surname><given-names>B</given-names></name><name><surname>Goeddeke</surname><given-names>S</given-names></name><name><surname>Koellmer</surname><given-names>C</given-names></name><name><surname>Jacob</surname><given-names>S</given-names></name><name><surname>Nitzgen</surname><given-names>U</given-names></name><name><surname>Passlack</surname><given-names>W</given-names></name><name><surname>Schiller</surname><given-names>M</given-names></name><name><surname>Dicken</surname><given-names>HD</given-names></name><name><surname>Haas</surname><given-names>J</given-names></name><name><surname>Muller-Wieland</surname><given-names>D</given-names></name><etal/></person-group><article-title>So close and yet so far: mitochondria and peroxisomes are one but with specific talents</article-title><source>Arch Physiol Biochem</source><year>2013</year><volume>119</volume><fpage>126</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">23705958</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Navarro</surname><given-names>MA</given-names></name><name><surname>Sanchez-Pulido</surname><given-names>L</given-names></name><name><surname>McBride</surname><given-names>HM</given-names></name></person-group><article-title>Mitochondrial vesicles: an ancient process providing new links to peroxisomes</article-title><source>Curr Opin Cell Biol</source><year>2009</year><volume>21</volume><fpage>560</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">19423315</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>S</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Tatemichi</surname><given-names>Y</given-names></name><name><surname>Fujiki</surname><given-names>Y</given-names></name></person-group><article-title>The membrane peroxin PEX3 induces peroxisome-ubiquitination-linked pexophagy</article-title><source>Autophagy</source><year>2014</year><volume>10</volume><fpage>1549</fpage><lpage>1564</lpage><pub-id pub-id-type="pmcid">PMC4206534</pub-id><pub-id pub-id-type="pmid">25007327</pub-id><pub-id pub-id-type="doi">10.4161/auto.29329</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bingol</surname><given-names>B</given-names></name><name><surname>Tea</surname><given-names>JS</given-names></name><name><surname>Phu</surname><given-names>L</given-names></name><name><surname>Reichelt</surname><given-names>M</given-names></name><name><surname>Bakalarski</surname><given-names>CE</given-names></name><name><surname>Song</surname><given-names>Q</given-names></name><name><surname>Foreman</surname><given-names>O</given-names></name><name><surname>Kirkpatrick</surname><given-names>DS</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><article-title>The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy</article-title><source>Nature</source><year>2014</year><volume>510</volume><fpage>370</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">24896179</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>CN</given-names></name><name><surname>Baughman</surname><given-names>JM</given-names></name><name><surname>Phu</surname><given-names>L</given-names></name><name><surname>Tea</surname><given-names>JS</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Coons</surname><given-names>M</given-names></name><name><surname>Kirkpatrick</surname><given-names>DS</given-names></name><name><surname>Bingol</surname><given-names>B</given-names></name><name><surname>Corn</surname><given-names>JE</given-names></name></person-group><article-title>USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria</article-title><source>Nat Cell Biol</source><year>2015</year><volume>17</volume><fpage>160</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">25621951</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>JR</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name><name><surname>Lane</surname><given-names>JD</given-names></name><name><surname>Mayor</surname><given-names>U</given-names></name><name><surname>Clague</surname><given-names>MJ</given-names></name><name><surname>Urbe</surname><given-names>S</given-names></name></person-group><article-title>USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death</article-title><source>EMBO Rep</source><year>2015</year><volume>16</volume><fpage>618</fpage><lpage>627</lpage><pub-id pub-id-type="pmcid">PMC4428036</pub-id><pub-id pub-id-type="pmid">25739811</pub-id><pub-id pub-id-type="doi">10.15252/embr.201439820</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gersch</surname><given-names>M</given-names></name><name><surname>Gladkova</surname><given-names>C</given-names></name><name><surname>Schubert</surname><given-names>AF</given-names></name><name><surname>Michel</surname><given-names>MA</given-names></name><name><surname>Maslen</surname><given-names>S</given-names></name><name><surname>Komander</surname><given-names>D</given-names></name></person-group><article-title>Mechanism and regulation of the Lys6-selective deubiquitinase USP30</article-title><source>Nat Struct Mol Biol</source><year>2017</year><volume>24</volume><fpage>920</fpage><lpage>930</lpage><pub-id pub-id-type="pmcid">PMC5757785</pub-id><pub-id pub-id-type="pmid">28945249</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.3475</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phu</surname><given-names>L</given-names></name><name><surname>Rose</surname><given-names>CM</given-names></name><name><surname>Tea</surname><given-names>JS</given-names></name><name><surname>Wall</surname><given-names>CE</given-names></name><name><surname>Verschueren</surname><given-names>E</given-names></name><name><surname>Cheung</surname><given-names>TK</given-names></name><name><surname>Kirkpatrick</surname><given-names>DS</given-names></name><name><surname>Bingol</surname><given-names>B</given-names></name></person-group><article-title>Dynamic Regulation of Mitochondrial Import by the Ubiquitin System</article-title><source>Mol Cell</source><year>2020</year><volume>77</volume><fpage>1107</fpage><lpage>1123</lpage><elocation-id>e1110</elocation-id><pub-id pub-id-type="pmid">32142684</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusilowicz-Jones</surname><given-names>EV</given-names></name><name><surname>Jardine</surname><given-names>J</given-names></name><name><surname>Kallinos</surname><given-names>A</given-names></name><name><surname>Pinto-Fernandez</surname><given-names>A</given-names></name><name><surname>Guenther</surname><given-names>F</given-names></name><name><surname>Giurrandino</surname><given-names>M</given-names></name><name><surname>Barone</surname><given-names>FG</given-names></name><name><surname>McCarron</surname><given-names>K</given-names></name><name><surname>Burke</surname><given-names>CJ</given-names></name><name><surname>Murad</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name><etal/></person-group><article-title>USP30 sets a trigger threshold for PINK1-PARKIN amplification of mitochondrial ubiquitylation</article-title><source>Life Sci Alliance</source><year>2020</year><volume>3</volume><pub-id pub-id-type="pmcid">PMC7362391</pub-id><pub-id pub-id-type="pmid">32636217</pub-id><pub-id pub-id-type="doi">10.26508/lsa.202000768</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsefou</surname><given-names>E</given-names></name><name><surname>Walker</surname><given-names>AS</given-names></name><name><surname>Clark</surname><given-names>EH</given-names></name><name><surname>Hicks</surname><given-names>AR</given-names></name><name><surname>Luft</surname><given-names>C</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Ramazio</surname><given-names>B</given-names></name><name><surname>Staddon</surname><given-names>JM</given-names></name><name><surname>Briston</surname><given-names>T</given-names></name><name><surname>Ketteler</surname><given-names>R</given-names></name></person-group><article-title>Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches</article-title><source>Biochem J</source><year>2021</year><volume>478</volume><fpage>4099</fpage><lpage>4118</lpage><pub-id pub-id-type="pmcid">PMC8718267</pub-id><pub-id pub-id-type="pmid">34704599</pub-id><pub-id pub-id-type="doi">10.1042/BCJ20210508</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhong</surname><given-names>G</given-names></name><name><surname>Zhuang</surname><given-names>M</given-names></name></person-group><article-title>Ubiquitin ligase MARCH5 localizes to peroxisomes to regulate pexophagy</article-title><source>J Cell Biol</source><year>2022</year><volume>221</volume><pub-id pub-id-type="pmcid">PMC8579195</pub-id><pub-id pub-id-type="pmid">34747980</pub-id><pub-id pub-id-type="doi">10.1083/jcb.202103156</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clague</surname><given-names>MJ</given-names></name><name><surname>Urbe</surname><given-names>S</given-names></name></person-group><article-title>Integration of cellular ubiquitin and membrane traffic systems: focus on deubiquitylases</article-title><source>FEBS J</source><year>2017</year><volume>284</volume><fpage>1753</fpage><lpage>1766</lpage><pub-id pub-id-type="pmcid">PMC5484354</pub-id><pub-id pub-id-type="pmid">28064438</pub-id><pub-id pub-id-type="doi">10.1111/febs.14007</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elcocks</surname><given-names>H</given-names></name><name><surname>Brazel</surname><given-names>AJ</given-names></name><name><surname>McCarron</surname><given-names>KR</given-names></name><name><surname>Kaulich</surname><given-names>M</given-names></name><name><surname>Husnjak</surname><given-names>K</given-names></name><name><surname>Mortiboys</surname><given-names>H</given-names></name><name><surname>Clague</surname><given-names>MJ</given-names></name><name><surname>Urbé</surname><given-names>S</given-names></name></person-group><article-title>FBXL4 deficiency promotes mitophagy by elevating NIX</article-title><source>bioRxiv</source><year>2022</year><elocation-id>2022.2010.2011.511735</elocation-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montava-Garriga</surname><given-names>L</given-names></name><name><surname>Singh</surname><given-names>F</given-names></name><name><surname>Ball</surname><given-names>G</given-names></name><name><surname>Ganley</surname><given-names>IG</given-names></name></person-group><article-title>Semi-automated quantitation of mitophagy in cells and tissues</article-title><source>Mech Ageing Dev</source><year>2020</year><volume>185</volume><elocation-id>111196</elocation-id><pub-id pub-id-type="pmcid">PMC6961211</pub-id><pub-id pub-id-type="pmid">31843465</pub-id><pub-id pub-id-type="doi">10.1016/j.mad.2019.111196</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>A chemical screen for pexophagy inducers.</title><p><bold>(A)</bold> Schematic for the Keima-SKL pexophagy reporter system. The Keima fluorescent reporter is targeted to the peroxisomal matrix via the peroxisomal targeting signal 1 (tripeptide SKL). Upon delivery to the acidic environment of lysosomes, the excitation spectrum of Keima is red shifted. Fluorescence emission from these two excitation wavelengths (445 and 561 nm) is pseudocoloured green and red respectively <bold>(B)</bold> Representative images of hTERT-RPE1 cells stably expressing the Keima-SKL pexophagy reporter. CMPD-39 (1 μM) was administered for 96 h before imaging. For all other conditions, cells were treated for 24 hours with MLN4924 (1 μM), 4-PBA (4-PBA, 1 mM), Clofibrate (20 μM), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>, 100 μM) and Deferiprone (DFP, 1 mM). Scale bar 20 μm. <bold>(C-D)</bold> Graphs illustrate the number and mean area of pexolysosomes per cell. Quantification of the data from three independent colour coded experiments is shown. Mean and standard deviation (SD) are indicated; &gt;40 cells were quantified per condition in each replicate experiment. One way ANOVA and Bonferroni’s multiple comparison test. *P&lt;0.05, **P&lt;0.01, ***P&lt;0.001, ****P&lt;0.0001 <bold>(E)</bold> Representative Western blot of hTERT-RPE1-Keima-SKL treated as in (B), probed for Cullin-2 (CUL2), PMP70, BNIP3, HIF1α, NIX and Actin. Arrow indicates the neddylated form of Cullin-2. <bold>(F-G-H)</bold> Quantitation of data shown in (E) indicating the mean and standard deviation for three independent colour coded experiments.</p></caption><graphic xlink:href="EMS156922-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>MLN4924-induced pexophagy requires NIX.</title><p><bold>(A)</bold> Representative confocal images of hTERT-RPE1-Keima-SKL cells treated with DMSO and MLN4924 (1 μM) for 24 h before imaging. Cells were transfected with non-targeting siRNA (NT1) or siRNA targeting BNIP3, NIX, ATG7, ACBD5 and NBR1. Scale bar 20 μm. <bold>(B-C)</bold> Graphs show the number and mean area of pexolysosomes. Quantification of the data from three colour coded independent experiments is shown. Mean and SD are indicated; &gt;40 cells were quantified per condition in each experiment. One-way ANOVA with Bonferroni’s multiple comparisons test. *P &lt; 0.05. **P &lt; 0.01. ***P &lt; 0.001. ****P &lt; 0.0001. <bold>(D)</bold> Representative Western blot of hTERT-RPE1-Keima-SKL cells treated as in (A) and probed as indicated. <bold>(E)</bold> Representative confocal images of hTERT-RPE1-Keima-SKL cells stably expressing the Keima-SKL pexophagy reporter. Cells were treated with DMSO and MLN4924 (1 μM), for 24 h before imaging. Cells were transfected with non-targeting (NT1) siRNA or siRNA targeting BNIP3 and NIX. Scale bar 20 μm. <bold>(F-G)</bold> Graph shows the number and mean area of pexolysosomes per cell. Quantification of the data from three colour-coded independent experiments is shown. Mean and standard deviation are indicated; &gt;40 cells were quantified per condition in each repeat experiment. One-way ANOVA with Bonferroni’s multiple comparisons test. **P &lt; 0.01. ***P &lt; 0.001. ****P &lt; 0.0001 <bold>(H)</bold> Representative Western blot of protein samples from cells treated as in (E) and probed as indicated.</p></caption><graphic xlink:href="EMS156922-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Exogenously expressed NIX colocalises with peroxisomes independently of mitochondria.</title><p><bold>(A)</bold> hTERT-RPE1-YFP-Parkin cells were first treated for 24 h with oligomycin A and antimycin A (AO,1 <italic>μ</italic>M each) or DMSO, then transiently transfected with DsRed-NIX or DsRed alone for 16 h prior to fixation or harvesting. <bold>(B)</bold> Representative images of cells, treated as described in (A), immunostained for endogenous PMP70 (AlexaFluor-405, green). A set of mock transfected cells treated in parallel were co-stained for TOMM20 (AlexaFluor-594, red). Scale bars 10 <italic>μ</italic>m. <bold>(C)</bold> Colocalisation of the DsRed-NIX signal with peroxisomes (PMP70) in hTERT-RPE1-YFP-Parkin cells treated with A/O. The Manders overlap coefficient (MOC, M1) was calculated for &gt;25 cells per experiment. The mean and standard deviation of three independent experiments is shown. <bold>(D)</bold> Representative Western blot showing subcellular fractions of hTERT-RPE1-YFP-Parkin cells treated as shown in (A). Post-nuclear supernatant (PNS) and light membranes (LM) are shown; representative of two independent experiments, red arrow indicates the mitochondria-depleted, DsRed-NIX transfected PNS and LM samples.</p></caption><graphic xlink:href="EMS156922-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>NBR1 mediates CMPD-39-induced pexophagy.</title><p><bold>(A)</bold> Representative confocal images of hTERT-RPE1-Keima-SKL cells treated with DMSO and CMPD-39 (1 μM), for 96 h before imaging. Cells were transfected with non-targeting (NT1) or siRNA or siRNA targeting BNIP3, NIX, ATG7, ACBD5 and NBR1. Scale bar 20 μm. Quantification of data shown in A. <bold>(B,C)</bold> Graphs show the number and mean area of pexolysosomes per cell from three independent colour coded experiments. Mean and standard deviation are indicated; &gt;50 cells were quantified per condition in each experiment. One-way ANOVA with Bonferroni’s multiple comparisons test. ***P &lt; 0.001. ****P &lt; 0.0001. <bold>(D)</bold> Representative Western blot of protein samples from cells treated as in (A) and probed as indicated. Low and high represent two different exposures of the same blot. <bold>(E)</bold> HIF1α-dependent and -independent pexophagy pathways. (i) HIF1α-dependent pexophagy pathway. Upon administration of the neddylation inhibitor, MLN4924, the transcription factor HIF1α is induced (top). This leads to the upregulation of NIX, which directly associates with peroxisomes and acts as a pexophagy adaptor. (ii) HIF1α-independent pexophagy pathway: the DUB USP30 suppresses pexophagy by removing ubiquitin attached to peroxisomal substrates. Accumulation of ubiquitin on peroxisomes, following USP30 inhibition, leads to the recruitment of the NBR1 pexophagy adaptor.</p></caption><graphic xlink:href="EMS156922-f004"/></fig></floats-group></article>